Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
Eisai shares 4523, +7.37% rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised ...
Read moreEisai shares 4523, +7.37% rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised ...
Read more
